
account no longer monitored. find me on Bluesky @Eomesodermin.bsky.social
Bonn, Germany
Joined October 2014
- Tweets2.2K
- Following1.8K
- Followers599
- Likes2K
🚨 Open #position! The group of Zeinab Abdullah is looking for a Technical Assistant/Research Assistant
Application deadline: October 30 immunosensation.de/opportuni…
🚨 Open #position! The group of Zeinab Abdullah is looking for a postdoc
Application deadline: October 30 immunosensation.de/opportuni…
🚨 Open #position! The group of Zeinab Abdullah is looking for two PhD students for
a) Characterisation of hepatic NK-like T cells
b) Dissecting the role of STING signalling in anti-viral T cell responses
Application deadline: October 30 immunosensation.de/opportuni…
My twitter/X feed has like many others become filled with Elon and Trump/Trump adjacent nonsense. I’m giving BlueSky a go and so far looks like a good portion of scitwitter has begun the migration. Come find me on the other app and let’s talk science.
I am excited to share our latest paper. We profiled CD8+ TILs from HPV- HNSCC patients using scRNA/TCRseq. In addition, we performed an ex vivo stimulation of cells to capture their transcriptional response. 1/n
onlinelibrary.wiley.com/doi/…
This paper scratches the surface of understanding how prolonged/sustained IFN impacts CD8+ TILs. We found it interesting that these cells can be observed in many scRNAseq datasets but are rarely mentioned. We hope this manuscript inspires others look further at these cells. 6/n
As always, many thanks to the patients and many collaborators. @Doc_Bald @IEO_baldlab @IEO_Bonn @theHumanBorch
Dillon Corvino retweeted
Following several kind requests, here is a high-level summary of our pre-print in @biorxivpreprint (doi: doi.org/10.1101/2024.10.03.6…):
STAMP: Single-Cell Transcriptomics Analysis and Multimodal Profiling through Imaging
STAMP is a scalable, cost-efficient method for single-cell transcriptomics and multimodal profiling through imaging. It bypasses sequencing, significantly reducing costs while enhancing throughput.
#SingleCellRNA #SpatialOmics #STAMP
The motivation for this paper comes from the limitations of current scRNA-seq methods, which are costly, inefficient, and struggle to capture low- and high-abundance transcripts. Challenges like droplet instability, cell damage, limited cell capture, cross-contamination, inefficient indexing, and high sequencing costs affect ultra-low and ultra-high cell profiling, hindering accurate analysis of complex cell populations. #Limitations #DropletMicrofluidics
STAMP addresses these issues with a scalable, cost-effective, sequencing(costs)-free approach that works efficiently across ultra-low to ultra-high cell numbers, while preserving cellular morphology and enabling multimodal profiling. #SpatialOmics #UltraLow #UltraHigh
STAMP uses an imaging-based approach to perform high-throughput RNA and protein profiling by stamping cells onto slides compatible with CosMx and Xenium platforms, allowing multimodal profiling in a single run.
#Proteomics
STAMP supports single-modal (RNA/protein) and multimodal (RNA + protein) profiling, enhancing experimental flexibility and scalability. This versatility is essential for large-scale atlases and mixed-sample experiments.
#SingleCellAtlas #MultiSampleProfiling
STAMP scales easily: from less than 100 to millions of cells. It overcomes limitations in droplet-based systems, where throughput is often constrained by sequencing costs.
#HighThroughput
STAMP handles diverse sample types: PBMCs, dissociated tumors, nuclei, and stem cells. It also excels with fragile or archived tissues, where traditional methods often fail to yield high-quality data.
#ArchivedSamples
STAMP eliminates sequencing costs, making large-scale single-cell analysis accessible to more labs. #CostEfficiency
Here’s a cost comparison between GEM-X and STAMP-X for RNA profiling:
GEM-X RNA (20k cells): $0.0764/cell
1M cells = $76,400 (cost/cell = $0.0764)
2M cells = $152.800 (cost/cell = $0.0764)
3M cells = $229,200 (cost/cell = $0.0764)
STAMP-X RNA (1M cells): $0.0075/cell
1M cells = $7,500 (cost/cell = $0.0075)
2M cells = $7,500 (cost/cell = $0.00375)
3M cells = $7,500 (cost/cell = $0.0025)
In STAMP cells remain intact after imaging, enabling further downstream applications like histological validation or additional molecular assays, adding value to each sample.
#NonDestructiveAnalysis
We tested STAMP’s sensitivity by identifying, ultra-rare, circulating tumor cells (CTCs) spiked into PBMCs at 1:100,000. Such sensitivity is essential for clinical diagnostics, particularly in rare cell detection.
#CTCs #CancerDiagnostics
In a high-throughput immuno-phenotyping experiment, STAMP profiled 1.7M PBMCs, capturing a median of 83 transcripts and 49 genes per cell. This resulted in high-resolution immune profiling.
#Immunology #HighThroughputProfiling
31 immune cell states were mapped in PBMCs, capturing rare subpopulations (Th1/Th2/Th17 and NK subtypes). Detailed immune phenotyping is critical for understanding immune diversity in health and disease.
#ImmuneMapping
Whole cells vs. nuclei: STAMP's ability to profile both whole cells and nuclei is crucial for samples with low RNA content (e.g., archived tissues), increasing the platform’s applicability.
#NucleiProfiling #SingleCellOmics
STAMP integrates RNA and protein profiling. In cancer cell line profiling, RNA and protein data showed strong correlations, confirming the platform’s robustness in multimodal data collection.
#MultimodalProfiling
STAMP’s multimodal profiling produced high-resolution immune maps, combining RNA and protein data. This approach is essential for dissecting complex immune states and understanding functional responses.
STAMP excels in low-input samples. We demonstrated its ability to accurately profile as few as 100 cells, which is critical for studying rare populations in small samples.
#LowInput #RareCell
In a BMP4-driven stem cell differentiation model, STAMP captured dynamic changes from pluripotency to mesoderm and endoderm progenitors over multiple timepoints, tracking lineage differentiation.
#StemCellDifferentiation #LineageTracing
Trajectory analysis shows that STAMP’s resolution makes it a powerful tool for developmental biology and perturbation studies.
#DevelopmentalBiology #hESC
STAMP allows multi-sample profiling on a single slide, reducing batch effects and improving comparative analysis, particularly in drug response and perturbation studies.
#MultiSampleAnalysis #PerturbationScreening
STAMP represents a significant advance in single-cell research, offering scalable, multimodal RNA/protein profiling at low cost. Its versatility will support a broad range of research, from basic to clinical.
#SingleCellTechnology
Lots more coming soon...
@DrJasPlummer @hoheyn @pascual_reguant @EmanuelePitino1 @helucro @ximbaozao @irepan_salvador @Kellieiswise @m_mohenska @jc_nietos @cnag_eu @StJudeResearch @ACEpigenetics @M_ayco_N @eliseinsing Bill Flynn, Yutian Liu, Hannah Chasteen
Dillon Corvino retweeted
Online now: T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels dlvr.it/TF0Kg6
Dillon Corvino retweeted
We are looking for a highly motivated PhD Student! 🤩
If you are passionate about science and interested in tumor immunology and metabolism… join us in Bonn! 👩🏻🔬👨🔬
please share🙏
Dillon Corvino retweeted
We developed an imaging-free spatial genomics technology where DNA barcodes diffuse to connect locally. Using UMAP, we reconstructed the physical locations of these barcodes, transforming spatial transcriptomics into purely molecular biology.
biorxiv.org/content/10.1101/…
Dillon Corvino retweeted
🚨New lab preprint! 🚨
A deep dive to shed light on a long-standing controversy with RNA-targeting CRISPRs: Do they have high levels of collateral (trans) cleavage of other RNAs in the cell ✂️✂️✂️ — or not?
New work from talented PhD student #SydneyHart & others in our lab. 📰
Dillon Corvino retweeted
Rikard Forlin from @BrodinPetter lab presents results of our collaboration with @PixelgenTech at #HumanImmun24
Cool technology btw😉
Dillon Corvino retweeted
This represents how we believe haematopoiesis is actually proceeding at a clonal level. I'll walk through our preprint early next week. "A multi-track landscape of haematopoiesis informed by cellular barcoding and agent-based modelling" biorxiv.org/content/10.1101/…
Dillon Corvino retweeted
Very excited (& nervous) to share what we've been working on the past many years. Only took 3 first authors (Schreuder the experimentalist, @DawnSLin the analyst, and @syzmath the modeller) & co-senior Weber (computational, modeller, SynBio extraordinaire) biorxiv.org/content/10.1101/…
This represents how we believe haematopoiesis is actually proceeding at a clonal level. I'll walk through our preprint early next week. "A multi-track landscape of haematopoiesis informed by cellular barcoding and agent-based modelling" biorxiv.org/content/10.1101/…
New preprint.
Herein we describe a subset of CD8+ TILs highly enriched in Type I interferon signalling genes. These cells can be observed in various tumor entities but we first saw them in our dataset of treatment-naive HPV- HNSCC TILs.
biorxiv.org/content/10.1101/…
Many questions still remain, for example, how do these cells arise? What are the functional consequences on patient prognosis and tumour outcomes?
Big thanks to the patients whose contribution to science was invaluable and to the many co-authors, especially @theHumanBorch, Matthias Braun, and @Doc_Bald.











